RaySearch Laboratories AB (publ) (27R.F)
Frankfurt · EUR · Healthcare · Health Information Services
€17.18 (+0.70%) as of
Key statistics
- Market cap
- 512.03M
- P/E (TTM)
- 30.14
- EPS (TTM)
- 0.57
- Dividend yield
- 2.14%
- 52-week range
- 14.73 – 23.20
- Beta
- 0.87
- Profit margin
- 16.77%
- Volume
- 640.00
About RaySearch Laboratories AB (publ)
RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer treatment worldwide. It offers RayStation, a treatment planning system for cancer centers; RayCare, an oncology information system for clinics; RayIntelligence, cloud-based oncology analytics system that cancer centers can use to gather, structure and analyze data; and RayCommand, a treatment control system designed to link the treatment machine and the treatment planning and oncology information systems. It also provides µ-RayStation* (Micro-RayStation), a software platform for planning and evaluation in small animal irradiation research; RayPlan, a treatment planning system; DrugLog, which verifies the identity and concentration of compounded injectables before administered to a patient; RayMigrate, allows users to convert Pinnacle patient data to RayStation format and/or to DICOM format; Machine Learning; and Liver Ablation Solutions. The company was founded in 2000 and is headquartered in Stockholm, Sweden.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Stockholm, Sweden
- Employees
- 464
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.